• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by CME Group Inc.

    3/23/26 4:17:52 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance
    Get the next $CME alert in real time by email
    DEFA14A 1 defa14anotice_2026.htm DEFA14A defa14anotice_2026
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant  Filed by a Party other than the Registrant Check the appropriate box:  Preliminary Proxy Statement  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))  Definitive Proxy Statement  Definitive Additional Materials  Soliciting Material Under §240.14a-12 CME GROUP INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box):  No fee required.  Fee paid previously with preliminary materials.  Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11


     
    *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V86978-P44742 20 S. WACKER DRIVE CHICAGO, IL 60606 Your Vote Counts! CME GROUP INC. 2026 Annual Meeting Vote by May 13, 2026 10:59 PM CT You invested in CME GROUP INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on May 14, 2026. Get informed before you vote View the Notice, Proxy Statement and CME Group 2025 Annual Report on Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 30, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Vote in Person at the Meeting* May 14, 2026 10:00 AM CT CME Group’s headquarters Auditorium 20 South Wacker Drive Chicago, IL


     
    Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V86979-P44742 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. The Board of Directors recommends votes “FOR” Proposals 1 through 7. 1. Election of Equity Directors Fourteen will be elected to the Board of Directors 1a. Terrence A. Duffy For 1b. Kathryn Benesh For 1c. Timothy S. Bitsberger For 1d. Charles P. Carey For 1e. Bryan T. Durkin For 1f. Harold Ford Jr. For 1g. Martin J. Gepsman For 1h. Daniel G. Kaye For 1i. Phyllis M. Lockett For 1j. Deborah J. Lucas For 1k. Rahael Seifu For 1l. William R. Shepard For 1m. Howard J. Siegel For 1n. Dennis A. Suskind For 2. Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. For 3. Advisory vote on the compensation of our named executive officers. For 4. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-1 shareholder to elect three directors. For 5. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-2 shareholder to elect two directors. For 6. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-3 shareholder to elect one director. For 7. Approval of an amendment to our certificate of incorporation that would remove provisions that would be inoperative if each of ITEMS 4, 5 and 6 are approved. For Class A Voting Items


     
    *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V86980-P44742 Your Vote Counts! CME GROUP INC. 2026 Annual Meeting Vote by May 13, 2026 10:59 PM CT Vote in Person at the Meeting* May 14, 2026 10:00 AM CT CME Group’s headquarters Auditorium 20 South Wacker Drive Chicago, IL 20 S. WACKER DRIVE CHICAGO, IL 60606 You invested in CME GROUP INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on May 14, 2026. Get informed before you vote View the Notice, Proxy Statement and CME Group 2025 Annual Report on Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 30, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.


     
    Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V86981-P44742 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. Class B-1 Voting Items The Board of Directors recommends votes “FOR” Proposals 1 through 7. 1. Election of Equity Directors Fourteen will be elected to the Board of Directors 1a. Terrence A. Duffy For 1b. Kathryn Benesh For 1c. Timothy S. Bitsberger For 1d. Charles P. Carey For 1e. Bryan T. Durkin For 1f. Harold Ford Jr. For 1g. Martin J. Gepsman For 1h. Daniel G. Kaye For 1i. Phyllis M. Lockett For 1j. Deborah J. Lucas For 1k. Rahael Seifu For 1l. William R. Shepard For 1m. Howard J. Siegel For 1n. Dennis A. Suskind For 2. Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. For 3. Advisory vote on the compensation of our named executive officers. For 4. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-1 shareholder to elect three directors. For 5. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-2 shareholder to elect two directors. For 6. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-3 shareholder to elect one director. For 7. Approval of an amendment to our certificate of incorporation that would remove provisions that would be inoperative if each of ITEMS 4, 5 and 6 are approved. For 8. Election of Three Class B-1 Directors The Nominating and Governance Committee recommends a vote “FOR” all of the Class B-1 director nominees. 8a. William W. Hobert (WH) For 8b. Patrick J. Mulchrone (PJM) For 8c. Robert J. Tierney Jr. (RJT) For


     
    *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V86982-P44742 Your Vote Counts! CME GROUP INC. 2026 Annual Meeting Vote by May 13, 2026 10:59 PM CT Vote in Person at the Meeting* May 14, 2026 10:00 AM CT CME Group’s headquarters Auditorium 20 South Wacker Drive Chicago, IL 20 S. WACKER DRIVE CHICAGO, IL 60606 You invested in CME GROUP INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on May 14, 2026. Get informed before you vote View the Notice, Proxy Statement and CME Group 2025 Annual Report on Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 30, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.


     
    Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V86983-P44742 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. Class B-2 Voting Items The Board of Directors recommends votes “FOR” Proposals 1 through 7. 1. Election of Equity Directors Fourteen will be elected to the Board of Directors 1a. Terrence A. Duffy For 1b. Kathryn Benesh For 1c. Timothy S. Bitsberger For 1d. Charles P. Carey For 1e. Bryan T. Durkin For 1f. Harold Ford Jr. For 1g. Martin J. Gepsman For 1h. Daniel G. Kaye For 1i. Phyllis M. Lockett For 1j. Deborah J. Lucas For 1k. Rahael Seifu For 1l. William R. Shepard For 1m. Howard J. Siegel For 1n. Dennis A. Suskind For 2. Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. For 3. Advisory vote on the compensation of our named executive officers. For 4. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-1 shareholder to elect three directors. For 5. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-2 shareholder to elect two directors. For 6. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-3 shareholder to elect one director. For 7. Approval of an amendment to our certificate of incorporation that would remove provisions that would be inoperative if each of ITEMS 4, 5 and 6 are approved. For 8. Election of One Class B-2 Director The Nominating and Governance Committee recommends a vote “FOR” the Class B-2 director nominee. 8a. Patrick W. Maloney (PAT) For


     
    *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V86984-P44742 Your Vote Counts! CME GROUP INC. 2026 Annual Meeting Vote by May 13, 2026 10:59 PM CT Vote in Person at the Meeting* May 14, 2026 10:00 AM CT CME Group’s headquarters Auditorium 20 South Wacker Drive Chicago, IL 20 S. WACKER DRIVE CHICAGO, IL 60606 You invested in CME GROUP INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on May 14, 2026. Get informed before you vote View the Notice, Proxy Statement and CME Group 2025 Annual Report on Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 30, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.


     
    Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V86985-P44742 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. Class B-3 Voting Items The Board of Directors recommends votes “FOR” Proposals 1 through 7. 1. Election of Equity Directors Fourteen will be elected to the Board of Directors 1a. Terrence A. Duffy For 1b. Kathryn Benesh For 1c. Timothy S. Bitsberger For 1d. Charles P. Carey For 1e. Bryan T. Durkin For 1f. Harold Ford Jr. For 1g. Martin J. Gepsman For 1h. Daniel G. Kaye For 1i. Phyllis M. Lockett For 1j. Deborah J. Lucas For 1k. Rahael Seifu For 1l. William R. Shepard For 1m. Howard J. Siegel For 1n. Dennis A. Suskind For 2. Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. For 3. Advisory vote on the compensation of our named executive officers. For 4. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-1 shareholder to elect three directors. For 5. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-2 shareholder to elect two directors. For 6. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-3 shareholder to elect one director. For 7. Approval of an amendment to our certificate of incorporation that would remove provisions that would be inoperative if each of ITEMS 4, 5 and 6 are approved. For 8. Election of One Class B-3 Director The Nominating and Governance Committee recommends a vote “FOR” the one Class B-3 director nominee. 8a. Elizabeth A. Cook (LZY) For


     
    *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V86986-P44742 Your Vote Counts! CME GROUP INC. 2026 Annual Meeting Vote by May 13, 2026 10:59 PM CT Vote in Person at the Meeting* May 14, 2026 10:00 AM CT CME Group’s headquarters Auditorium 20 South Wacker Drive Chicago, IL 20 S. WACKER DRIVE CHICAGO, IL 60606 You invested in CME GROUP INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on May 14, 2026. Get informed before you vote View the Notice, Proxy Statement and CME Group 2025 Annual Report on Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 30, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.


     
    Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V86987-P44742 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. Class B-4 Voting Items The Board of Directors recommends votes “FOR” Proposals 1 through 7. 1. Election of Equity Directors Fourteen will be elected to the Board of Directors 1a. Terrence A. Duffy For 1b. Kathryn Benesh For 1c. Timothy S. Bitsberger For 1d. Charles P. Carey For 1e. Bryan T. Durkin For 1f. Harold Ford Jr. For 1g. Martin J. Gepsman For 1h. Daniel G. Kaye For 1i. Phyllis M. Lockett For 1j. Deborah J. Lucas For 1k. Rahael Seifu For 1l. William R. Shepard For 1m. Howard J. Siegel For 1n. Dennis A. Suskind For 2. Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. For 3. Advisory vote on the compensation of our named executive officers. For 4. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-1 shareholder to elect three directors. For 5. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-2 shareholder to elect two directors. For 6. Approval of an amendment to our certificate of incorporation to eliminate the right of the Class B-3 shareholder to elect one director. For 7. Approval of an amendment to our certificate of incorporation that would remove provisions that would be inoperative if each of ITEMS 4, 5 and 6 are approved. For


     
    Get the next $CME alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CME

    DatePrice TargetRatingAnalyst
    4/8/2026$305.00Mkt Perform
    Keefe Bruyette
    3/4/2026Buy → Hold
    Argus
    1/14/2026$305.00Hold → Buy
    TD Cowen
    10/23/2025$300.00Hold → Buy
    Deutsche Bank
    9/25/2025$300.00Neutral → Buy
    Citigroup
    7/24/2025$305.00Buy → Neutral
    UBS
    4/8/2025$301.00Equal-Weight → Overweight
    Morgan Stanley
    3/10/2025$287.00Mkt Perform → Outperform
    Raymond James
    More analyst ratings

    $CME
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Shepard William R bought $73,008 worth of Common Stock Class A (262 units at $278.37), increasing direct ownership by 0.45% to 2,477 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    1/2/26 2:30:36 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Director Shepard William R bought $72,672 worth of Common Stock Class A (274 units at $265.19), increasing direct ownership by 0.47% to 2,466 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    9/26/25 8:46:02 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Director Shepard William R was granted 879 units of Common Stock Class A and bought $72,336 worth of Common Stock Class A (267 units at $270.53), increasing direct ownership by 0.46% to 2,455 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    6/26/25 6:11:41 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Sr MD & Chief HR Officer Piell Hilda Harris sold $1,752,536 worth of Common Stock Class A (5,753 units at $304.63), decreasing direct ownership by 17% to 27,702 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    5/19/26 4:22:40 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Chairman and CEO Duffy Terrence A sold $10,447,866 worth of Common Stock Class A (35,000 units at $298.51), decreasing direct ownership by 39% to 55,630 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    5/18/26 4:12:15 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 4 filed by Shepard William R

    4 - CME GROUP INC. (0001156375) (Issuer)

    3/30/26 5:30:28 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CME Group May Volume Hits New Record of 33.2 Million Contracts, Up 15% Year Over Year

    Record ADV in 2-year U.S. Treasury futuresInternational ADV grew 18% to 10.2 million contractsCHICAGO, June 2, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its highest May average daily volume (ADV) on record at 33.2 million contracts, an increase of 15% year-over-year. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume. May 2026 ADV across asset classes includes:Interest Rate ADV of 18.8 million contractsEquity Index ADV of 8 million contractsEnergy ADV of 2.7 million contractsAgricultural ADV of 1.9 million contractsMetals ADV of 930,000 contractsForeign Exchange ADV of 901,000 contractsCryptocu

    6/2/26 7:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Announces Launch of 24/7 Cryptocurrency Futures and Options Trading

    CHICAGO, June 1, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it launched 24/7 trading for Cryptocurrency futures and options. The expanded trading hours, which went live on Friday, May 29, mark a significant milestone in providing global market participants with always-on access to regulated digital asset risk management tools. Over its inaugural weekend, more than 7,200 Cryptocurrency futures and options contracts were traded (~$50 million in notional), demonstrating immediate liquidity and clear demand for transparent, trusted markets. Volume was supported by a healthy ecosystem of retail and institutional firms."By offering continuous liqui

    6/1/26 3:38:00 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Chairman and Chief Executive Officer Terry Duffy to Present at Piper Sandler Global Exchange and Fintech Conference

    CHICAGO, May 29, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that Terry Duffy, Chairman and Chief Executive Officer, will present at the Piper Sandler Global Exchange and Fintech Conference on Thursday, June 4, 2026, at 2:00 p.m. (Eastern Time). The presentation will be available for livestreaming via CME Group's Investor Relations website. Please allow extra time prior to the presentation to visit the site and download the streaming media software required to listen to the online broadcast. An audio webcast will be available for replay at the same address approximately 24 hours following the conclusion of the conference.  As the world's leadi

    5/29/26 7:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Keefe Bruyette resumed coverage on CME Group with a new price target

    Keefe Bruyette resumed coverage of CME Group with a rating of Mkt Perform and set a new price target of $305.00

    4/8/26 8:35:44 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group downgraded by Argus

    Argus downgraded CME Group from Buy to Hold

    3/4/26 8:23:45 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group upgraded by TD Cowen with a new price target

    TD Cowen upgraded CME Group from Hold to Buy and set a new price target of $305.00

    1/14/26 8:20:33 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    SEC Filings

    View All

    SEC Form DEFA14A filed by CME Group Inc.

    DEFA14A - CME GROUP INC. (0001156375) (Filer)

    5/19/26 4:24:04 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CME GROUP INC. (0001156375) (Filer)

    5/19/26 4:21:13 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 8-K filed by CME Group Inc.

    8-K - CME GROUP INC. (0001156375) (Filer)

    4/27/26 4:38:50 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Leadership Updates

    Live Leadership Updates

    View All

    CME Group Inc. Announces Preliminary Results of 2026 Annual Meeting

    CHICAGO, May 14, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today announced the preliminary shareholder voting results from its 2026 annual meeting. At the meeting, shareholders:Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford Jr., Martin J. Gepsman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2027.Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2026.Approved, on an advisory basis, the compensation of our named executive officers.The offici

    5/14/26 3:00:00 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Leading Financial Institutions to Join BrokerTec Chicago for First Day of Trading

    New Central Limit Order Book for U.S. Treasury Trading to Launch Oct. 6CHICAGO, Sept. 4, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that Citigroup, J.P. Morgan and Morgan Stanley will be available to trade cash U.S. Treasuries on BrokerTec Chicago when it launches on October 6. "With leading financial firms on board for day one on BrokerTec Chicago, trading U.S. Treasury futures and cash will be more efficient than ever before," said Mike Dennis, CME Group Global Head of Fixed Income. "CME Group is in a unique position to bring these markets together, unlocking value for our clients worldwide who want to more precisely hedge their risk amid

    9/4/25 8:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. Announces Preliminary Results from its 2025 Annual Meeting of Shareholders

    CHICAGO, May 9, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today announced the preliminary shareholder voting results from its 2025 annual meeting. At the meeting, shareholders: Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford Jr., Martin J. Gepsman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2026.Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2025.Approved, on an advisory basis, the compensation of our named executive officers.There was

    5/9/25 10:29:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Financials

    Live finance-specific insights

    View All

    CME Group Declares Quarterly Dividend

    CHICAGO, May 7, 2026 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a second-quarter dividend of $1.30 per share. The dividend is payable June 25, 2026, to shareholders of record as of June 9, 2026. As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies,

    5/7/26 7:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. Reports Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2026

    Record revenue of $1.9 billion, up 14%Net income and diluted earnings per share both up 20%CHICAGO, April 22, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the first quarter of 2026. The company reported revenue of $1.9 billion and operating income of $1.3 billion for the first quarter of 2026. Net income was $1.2 billion and diluted earnings per common share were $3.18. On an adjusted basis, operating income was $1.4 billion, net income was $1.2 billion and diluted earnings per common share were $3.36. Financial results presented on an adjusted basis for the first quarter of 2026 and 2025 exclude certain items, which are detailed in the reconciliation

    4/22/26 7:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group to Expand Equity Index Dividend Suite with New Mid-Curve Options and Quarterly Futures

    CHICAGO, April 15, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced plans to expand its Equity Index Dividend suite on May 11, with the addition of Mid-curve options on S&P 500 Annual Dividend Index futures, alongside Nasdaq-100 and Russell 2000 Quarterly Dividend Index futures, pending regulatory review. "Amid shifting interest rates and economic uncertainty, managing dividend exposure has become a strategic necessity for investors," said Joe Hickey, Global Head of Equity Products at CME Group. "Trading in our dividend products has increased more than 50% year-over-year. To meet this increased demand, we are launching these new Mid-curve options o

    4/15/26 9:05:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/13/24 5:02:29 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/13/23 2:49:27 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/11/22 3:04:00 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance